The first Actos lawsuit has gone to trial in a California Superior Court in Los Angeles, known as Cooper v. Takeda Pharmaceuticals America Inc. Cooper v. Takeda is being heard by Judge Kenneth Freeman in California. The plaintiff in the case claims that Takeda failed to warn that one of the risks connected to the diabetes drug is bladder cancer.
To date, there are over 3,000 Actos bladder cancer lawsuits that have been filed against Takeda across the United States in states like California, Illinois, and Louisiana.
In Louisiana, approximately 1,200 Actos lawsuits have been consolidated into a multi-district litigation (MDL). Actos MDL court documents show that the first Actos MDL trial is scheduled for November 2014.
In a report from Bloomberg News, a Takeda representative has publicly stated that the pharmaceutical company has acted appropriately in its response to reports of patients developing bladder cancer linked to Actos ingestion.
However, a U.S. Food and Drug Administration (FDA) analyses of a ten year study conducted by Takeda Pharmaceuticals and Kaiser Permanente Northern California illustrates “increased risk of bladder cancer among patients with the longest exposure to Actos”. Furthermore, the FDA also cited an increased risk of developing bladder cancer in those individuals who ingest high doses of Actos.
Lawyers at Carey Danis & Lowe encourage individuals who have been injured by Actos to contact the law firm for a free legal evaluation and to file an Actos lawsuit. Carey Danis & Lowe believes that it is important to protect consumers and hold negligent pharmaceutical companies, like Takeda, responsible for releasing a harmful drug onto the market.
Contact an experienced trial lawyer at Carey Danis & Lowe by calling 800.721.2519 or by filling out the Carey Danis & Lowe legal claims form.References: Actos, Pharmaceutical litigation